Published in Immunol Lett on February 26, 2005
Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol (2008) 3.10
Biomarkers of nephrotoxic acute kidney injury. Toxicology (2008) 1.55
Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc Natl Acad Sci U S A (2006) 0.98
IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol (2014) 0.86
IL-18 induces profibrotic renal tubular cell injury via STAT3 activation. Am J Physiol Renal Physiol (2013) 0.86
Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. World J Gastroenterol (2008) 0.86
Renal IL-18 production is macrophage independent during obstructive injury. PLoS One (2012) 0.80
New biomarkers for the quick detection of acute kidney injury. ISRN Nephrol (2012) 0.78
IL-18 activation is dependent on Toll-like receptor 4 during renal obstruction. J Surg Res (2012) 0.77
Interleukin-18 and NGAL in assessment of ESWL treatment safety in children with urolithiasis. Cent Eur J Immunol (2014) 0.77
The pathological role of IL-18Rα in renal ischemia/reperfusion injury. Lab Invest (2014) 0.76
Genetic polymorphisms of Interleukin-18 are not associated with allograft function in kidney transplant recipients. Genet Mol Biol (2014) 0.75
Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. Clin Kidney J (2016) 0.75
Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model. PLoS One (2017) 0.75
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients. Transpl Int (2007) 2.03
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant (2012) 1.80
Kidney retransplantation following graft loss to polyoma virus-associated nephropathy: an effective treatment option in simultaneous pancreas and kidney transplant recipients. Transpl Int (2007) 1.44
Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation (2007) 1.42
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
Magnetic resonance imaging of pancreatic islets in tolerance and rejection. Transplantation (2005) 1.21
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant (2006) 1.17
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study. J Am Soc Nephrol (2005) 1.06
Secondary membranous nephropathy--one center experience. Ren Fail (2005) 0.93
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation. Transpl Int (2012) 0.92
Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues. Pancreas (2013) 0.91
No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res Clin Pract (2006) 0.90
The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience. Nephrol Dial Transplant (2011) 0.89
Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation. Diabetes Care (2008) 0.88
Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience. Ther Apher Dial (2009) 0.87
Intrarenal cytokine and chemokine gene expression and kidney graft outcome. Kidney Blood Press Res (2007) 0.86
Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progression. Nephrol Dial Transplant (2010) 0.86
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl (2010) 0.85
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol (2011) 0.85
Labeling of pancreatic islets with iron oxide nanoparticles for in vivo detection with magnetic resonance. Transplantation (2008) 0.85
Molecular phenotypes of acute rejection predict kidney graft prognosis. J Am Soc Nephrol (2009) 0.85
Evaluation of reference genes and normalization strategy for quantitative real-time PCR in human pancreatic carcinoma. Dis Markers (2012) 0.85
Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range. Transplantation (2002) 0.85
Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol (2004) 0.85
Cured malakoplakia of the renal allograft followed by long-term good function: a case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2012) 0.84
The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer. Cancer Chemother Pharmacol (2013) 0.83
Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. Respir Med (2008) 0.82
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Transplantation (2015) 0.82
CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines. APMIS (2009) 0.82
Cytokine gene expression profile in monocytic cells after a co-culture with epithelial cells. Immunol Res (2012) 0.81
Prevalence and risk of hypertension in renal disease--data from the Czech Registry of Renal Biopsies. Kidney Blood Press Res (2008) 0.80
Kidney transplantation in type 2 diabetic patients: a comparison with matched non-diabetic subjects. Nephrol Dial Transplant (2002) 0.80
Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens. Transpl Int (2005) 0.80
Cytokine gene polymorphisms and high-resolution-computed tomography score in idiopathic pulmonary fibrosis. Respir Med (2006) 0.79
Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study. Kidney Blood Press Res (2008) 0.78
IgA nephropathy in Czech patients--are we able reliably predict the outcome? Kidney Blood Press Res (2014) 0.78
Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis. Kidney Blood Press Res (2006) 0.78
Delayed administration of FK 506 is sufficient to suppress acute rejection changes after aortal transplantation in rats. Transpl Int (2007) 0.78
Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011. J Nephrol (2014) 0.78
Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft. Transpl Immunol (2011) 0.78
Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft. Transpl Immunol (2007) 0.77
Estimated and measured donor creatinine clearance are poor predictors of long-term renal graft function and survival. Am J Transplant (2002) 0.77
Asymmetric dimethylarginine in obesity after renal transplantation. J Ren Nutr (2008) 0.77
Treatment of lupus nephritis with cyclosporine - an outcome analysis. Kidney Blood Press Res (2007) 0.77
Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation. Exp Lung Res (2009) 0.76
Asymmetric dimethylarginine and adiponectin after renal transplantation: role of obesity. J Ren Nutr (2008) 0.76
Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis. World J Gastroenterol (2013) 0.76
Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol (2005) 0.76
Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft function. Transplantation (2014) 0.76
Potential predictive markers in protocol biopsies for premature renal graft loss. Kidney Blood Press Res (2010) 0.76
IL-18 receptor expression on epithelial cells is upregulated by TNF alpha. Inflammation (2005) 0.76
Identification of expanded-criteria donor kidney grafts at lower risk of delayed graft function. Transplantation (2013) 0.75
Commentary on the highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Nephrol Dial Transplant (2006) 0.75
Antibodies to HLA class II antigens as a risk factor for acute rejection of the allogeneic kindey. Ann Transplant (2004) 0.75
Conversion to sirolimus of patients with chronic allograft nephropathy--a retrospective analysis of outcome and influencing factors. Langenbecks Arch Surg (2008) 0.75
Molecular patterns of subclinical and clinical rejection of kidney allograft: quantity matters. Kidney Blood Press Res (2015) 0.75
Metabolic syndrome after renal transplantation. Med Pregl (2007) 0.75
Preservation injury to the human small bowel graft: jejunum vs. ileum. Ann Transplant (2007) 0.75
Medical-record review of potential donor pool in the Czech Republic suggests a possible increase to more than double the number of donors. Transpl Int (2003) 0.75
Gemcitabine does not prevent acute rejection of the transplanted liver in rats. Transpl Int (2004) 0.75
Number of serotonin positive cells and acute cellular rejection in the early period after small bowel transplantation in pigs. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2010) 0.75
Immunotactoid glomerulonephritis as a cause of acute renal failure. Nephrol Dial Transplant (2004) 0.75